Abcoude, Netherlands

Johannes Maria Aerts


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Johannes Maria Aerts

Introduction

Johannes Maria Aerts is a notable inventor based in Abcoude, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of human chitinase. His work focuses on the recombinant production and therapeutic applications of this enzyme.

Latest Patents

Aerts holds two patents related to human chitinase. His latest patents include a new human chitinase with a specific amino acid sequence, which has been designed for decomposing chitin. This invention also encompasses modified forms of the enzyme that maintain similar chitin-hydrolyzing activity, as well as antigenic peptides representing its epitopes. The patents detail the recombinant production of human chitinase using genetically engineered hosts, along with the development of recombinant nucleic acids and specific oligonucleotides. Furthermore, these innovations are aimed at therapeutic or prophylactic treatments against infections caused by chitin-containing pathogens and for decomposing chitin from various sources. Diagnostic test kits that incorporate human chitinase, its antigenic peptides, antibodies, and recombinant nucleic acids are also part of his patented work.

Career Highlights

Johannes Maria Aerts is affiliated with the Universiteit van Amsterdam, where he continues to advance research in biotechnology. His academic and research endeavors have positioned him as a key figure in the study of enzymes and their applications in medicine.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Johannes Maria Aerts is a pioneering inventor whose work on human chitinase has the potential to impact therapeutic treatments significantly. His contributions to biotechnology exemplify the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…